血清胱抑素C与心房颤动关系的最新研究进展
Recent Advances in the Relationship between Serum Cystatin C and Atrial Fibrillation
DOI: 10.12677/ACM.2023.132221, PDF,    科研立项经费支持
作者: 陈 娟：青海大学，青海 西宁；马晓峰*：青海省心脑血管病专科医院，青海 西宁
关键词: 综述；心房颤动；血清胱抑素C；Summary； Atrial Fibrillation； Serum Cystatin C
摘要: 近年生物标志物血清胱抑素C广泛地应用于心血管系统疾病的诊断、治疗及预后的判断。血清胱抑素C与心房颤动(房颤)的关系也逐步引起学者的关注。大量研究表明血清胱抑素C与房颤关系密切，在预测房颤等心血管疾病的临床应用中，血清胱抑素C作为廉价和容易获得的生物标志物的代表，还具有更大的研究潜力。
Abstract: In recent years, the biomarker serum cystatin C has been widely used in the diagnosis, treatment and prognosis of cardiovascular diseases. The relationship between serum cystatin C and atrial fi-brillation (AF) has gradually attracted the attention of scholars. A large number of studies have shown that serum cystatin C is closely related to atrial fibrillation. In the clinical application of pre-dicting atrial fibrillation and other cardiovascular diseases, serum cystatin C, as a representative of cheap and easily available biomarkers, has greater research potential.
文章引用：陈娟, 马晓峰. 血清胱抑素C与心房颤动关系的最新研究进展[J]. 临床医学进展, 2023, 13(2): 1607-1611. https://doi.org/10.12677/ACM.2023.132221

参考文献

[1] 黄小琳, 高沛, 王龙, 等. 糖尿病与糖尿病前期人群胱抑素C与心血管疾病早期病变的相关性[J]. 中国老年学杂志, 2021, 4(41): 1378-1382.
[2] Zheng, T., Li, L., Yi, M., et al. (2019) Clinical Significance of Cys-C and hs-CRP in Coronary Heart Disease Patients Undergoing Percutaneous Coronary Intervention. Brazilian Journal of Cardiovascular Surgery, 34, 17-21. [Google Scholar] [CrossRef] [PubMed]
[3] Mohd Tahir, N.A., Mohd Saffian, S., Islahudin, F.H., et al. (2020) Effects of CST3 Gene G73A Polymorphism on Cystatin C in a Prospective Multiethnic Cohort Study. Nephron, 144, 204-212. [Google Scholar] [CrossRef] [PubMed]
[4] 田玉娥, 刘江杰, 杨克健. 银屑病患者心理健康状况及人格特征研究[J]. 医学信息旬刊, 2011, 24(6): 3392-3395.
[5] 朱蓓蓓, 王妍妍, 曹春艳. 银屑病病人开展强化自我管理行为干预的效果[J]. 护理研究, 2013, 27(1A): 62-64.
[6] 梁鹏, 周芳. 老年慢性房颤患者血清热休克蛋白70和胱抑素C的表达及意义[J]. 河北医学, 2015(9): 1455-1458.
[7] Guo, Y., Tian, Y., Wang, H., et al. (2015) Prevalence, Incidence, and Lifetime Risk of Atrial Fibrillation in China: New Insights into the Global Burden of Atrial Fibrillation. Chest, 147, 109-119. [Google Scholar] [CrossRef] [PubMed]
[8] 王增夏, 王贺, 邱承杰, 等. 心房颤动发病机制的研究进展[J]. 中国医药导报, 2018(15): 26-29.
[9] 白玲玉, 贺利平. 心房颤动与Cys C、TGF-β1、TNF-α、CRP、CA125的研究进展[J]. 中西医结合心血管病电子杂, 2020, 3(8): 8-76.
[10] 叶声, 唐忠平, 林凤, 等. 脓毒症AKI患者Cys C、GFR和循环RAAS水平变化与预后的相关性[J]. 西部医学, 2019, 31(12): 1875-1878.
[11] Frustaci, A., et al. (1997) Histological Substrate of Atrial Biopsies in Patients with Lone Atrial Fibril-lation. Circulation, 96, 1180-1184. [Google Scholar] [CrossRef] 
[12] Pavlović, M., et al. (2017) The Association between Galectin-3 and hs-CRP and the Clinical Outcome after Non-ST-Elevation Myocardial Infarction with Preexisting Atrial Fibrillation. Scientific Reports, 7, Article No. 15106. [Google Scholar] [CrossRef] [PubMed]
[13] 王锡惠, 陶以嘉, 腾名子, 等. 血清胱抑素C水平与慢性心力衰竭患者房颤发生率的相关性[J]. 中国老年学杂志, 2018, 38(2): 320-322.
[14] Huang, R. and Chen, X. (2019) Increased Spot Urine Albumin-to-Creatinine Ratio and Stroke Incidence: A Systematic Review and Meta-Analysis. Journal of Stroke and Cerebrovascular Diseases, 28, Article ID: 104260. [Google Scholar] [CrossRef] [PubMed]
[15] 中华心血管病杂志血栓循环工作组. 非瓣膜病心房颤动患者应用新型口服抗凝药中国专家建议[J]. 中华心血管病杂志, 2014, 42(5): 362-369.

为你推荐